Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus

Vaccine

Volumn 14, Issue 6, 1996, Pages 485-491

  Fukushima, Akihisa ^a   Yoo, Yung Choon ^a   Yoshimatsu, Kumiko ^a   Matsuzawa, Kaori ^a   Tamura, Mizuho ^a   Tono Oka, Shuichi ^a   Taniguchi, Koki ^b   Urasawa, Shozo ^b   Arikawa, Jiro ^a   Azuma, Ichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Host resistance; MDP Lys(L18); Mucosal immunoadjuvant; Rotavirus; Sendai virus

Indexed keywords

IMMUNOLOGICAL ADJUVANT; MURAMYL DIPEPTIDE; MURAMYL DIPEPTIDE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIARRHEA; FEMALE; HOST RESISTANCE; IMMUNOMODULATION; INTESTINE; INTRANASAL DRUG ADMINISTRATION; LUNG; MALE; MOUSE; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; ROTAVIRUS; SENDAI VIRUS; VIRUS INFECTION;

EID: 0030004029     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00236-T     Document Type: Article

References (31)

1. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mocosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88
2. Mcclermott, M.R. and Bienenstock, J. Evidence for a common mucosal immunologic system. J. Immunol. 1979, 122, 1892-1898
3. Mestecky, J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 1987, 7, 265-276
4. Elson, C.O. and Ealding, W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 1984, 132, 2736-2741
5. Chanock, R.M. and Kenneth, M. Parainfluenza viruses. In: Virology, 2nd edn (Eds Fields, B.N. and Knipe, D.M.). Raven Press Ltd, New York, 1990, pp. 963-988
6. Kapikian, A.Z. and Chanock, R.M. Rotaviruses. In: Virology, 2nd edn (Eds Fields, B.N. and Knipe, D.M.). Raven Press Ltd, New York, 1990, pp. 1353-1404
7. Ellouz, F., Adam, A., Ciorbaru, R. and Lederer, E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 1974, 59, 1317-1325
8. Azuma, I., Kamisango, K., Saiki, I., Tanio, Y., Kobayashi, S. and Yamamura, Y. Adjuvant activity N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Infect. Immun. 1980, 29, 1193-1196
9. Azuma, I. Synthetic immunoadjuvants: application to non-specific host stimulation and potentiation of vaccine immunogenicity. Vaccine 1992, 10, 1000-1006
10. Ishihara, C., Hamada, N., Yamamoto, K., Iida, J., Azuma, I. and Yamamura, Y. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice. Vaccine 1985, 3, 370-374
11. α-acetylmuramyl-L-alanyl-D-isoglutaminyl-Nε-stearoyl-L- lysine in mice. Vaccine 1987, 5, 295-301
12. Estes, M.K., Graham, D.Y., Gerba, C.P. and Smith, E.M. Simian rotavirus SA11 replication in cell cultures. J. Virol. 1979, 31, 810-815
13. Hjelt, K., Grauballe, P.C., Paerregaard, A., Nielsen, O.H. and Krasilnikoff, P.A. Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J. Med. Virol. 1987, 21, 39-47
14. Flores, J., P-Schael, I., Gonzalez, M. et al. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1987, 18, 882-884
15. Offit, P.A., Clark, H.F., Kornstein, M.J. and Plotkin, S.A. A murine model for oral infection with a primate rotavirus (simian SA11). J. Virol. 1984, 51, 233-236
16. Yoo, Y.C., Saiki, I., Sato, K. and Azuma, I. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and nonhaematogenous tumours in mice. Vaccine 1994, 12, 175-180
17. Abraham, E. and Robinson, A. Oral immunization with bacterial polysaccharide and adjuvant enhances antigen-specific pulmonary secretory antibody response and resistance to pneumonia. Vaccine 1991, 9, 757-764
18. Nedrud, J.G., Liang, X., Hague, N. and Lamm, M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 1987, 139, 3484-3492
19. Liang, X., Lamm, M.E. and Nedrud, J.G. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol. 1988, 141, 1495-1501
20. Waldman, R.H., Stone, J., Bergmann, K.-Ch. et al. Secretory antibody following oral influenza immunization. Am. J. Med. Sci. 1986, 292, 367-371
21. Bergmann, K.-Ch., Waldman, R.H.Tischner, H. and Pohl. W.-D. Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine. Int. Archs Allergy Appl. Immunol. 1986, 80, 107-109
22. Haneberg, B., Kendall, D., Amerongen, H.M., Apter, F.M., Kraehenbuhl, J-P. and Neutra, M.R. Induction of specific Immunoglobulin A in the small intestine, colonrectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 1994, 62, 15-23
23. Montgomery, P.C., Ayyildiz, A., Lemaitre-Coelho, I.M., Vaerman, J-R. and Rockey, J.H. Induction and expression of antibodies in secretions: the ocular immune system. Ann. NY Acad. Sci. 1983, 409, 428-440
24. Williams, R.C. and Gibbons, R.J. Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science 1972, 177, 697-699
25. Tagliabue, A., Nencioni, L., Villa, L., Keren, D.F., Lowell, G.H. and Boraschi, D. Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature 1983, 306, 184-186
26. Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986, 59, 301-308
27. Wilson, A.D., Bailey, M., Williams, N.A. and Stokes, C.R. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur. J. Immunol. 1991, 21, 2333-2339
28. Xu-Amano, J., Kiyono, H., Jackson, R.J. et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 1993, 178, 1309-1320
29. Vajely, M. and Lycke, N. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant. Immunology 1993, 80, 197-203
30. Hornquist, E. and Lycke, N. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 1993, 23, 2136-2143
31. Tamura, M., Yoo, Y.C., Yoshimatsu, K. et al. Effect of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen. Vaccine 1995, 13, 77-82